Skip to main content

Market Overview

22 Stocks Moving In Thursday's Pre-Market Session

Share:

Gainers

  • HTG Molecular Diagnostics Inc (NASDAQ: HTGM) rose 14.3 percent to $2.16 in pre-market trading after falling 3.08 percent on Wednesday.
  • Halozyme Therapeutics, Inc. (NASDAQ: HALO) rose 13.1 percent to $14.90 in pre-market trading. Bristol-Myers and Halozyme disclosed a collaboration and license agreement using Halozyme's ENHANZE technology. Halozyme Therapeutics raised its FY sales outlook.
  • Autoliv Inc. (NYSE: ALV) rose 9.7 percent to $124.22 in pre-market trading. Autoliv initiated strategic review to consider separation of business segments into Passive Safety and Electronics.
  • Teekay Offshore Partners L.P. (NYSE: TOO) shares rose 9 percent to $2.68 in the pre-market trading session. Wells Fargo upgraded Teekay Offshore Partners from Market Perform to Outperform.
  • Tenet Healthcare Corp (NYSE: THC) rose 8.4 percent to $17.60 in pre-market trading. Tenet Healthcare is exploring options, including a possible sale, Dow Jones reported.
  • 22nd Century Group Inc (NASDAQ: XXII) rose 8 percent to $3.25 in pre-market trading after surging 12.31 percent on Wednesday.
  • United Natural Foods, Inc. (NASDAQ: UNFI) shares rose 6.2 percent to $39.50 in pre-market trading after the company reported stronger-than-expected earnings for its fourth quarter.
  • Reata Pharmaceuticals Inc (NASDAQ: RETA) rose 5.1 percent to $32.00 in pre-market trading after the company disclosed that the FDA has granted orphan designation to omaveloxolone for the treatment of malignant melanoma.
  • Tower Semiconductor Ltd. (USA) (NASDAQ: TSEM) rose 3.5 percent to $30.10 in pre-market trading after gaining 0.31 percent on Wednesday.
  • Tata Motors Limited (ADR) (NYSE: TTM) rose 3.3 percent to $31.49 in pre-market trading after falling 0.36 percent on Wednesday.
  • Hexcel Corporation (NYSE: HXL) rose 3.2 percent to $56.20 in pre-market trading after gaining 0.63 percent on Wednesday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • BiondVax Pharmaceuticals Ltd (ADR) (NASDAQ: BVXV) fell 16 percent to $6.41 in pre-market trading. BiondVax priced its 1.5 million ADS offering at $6.00 per ADS.
  • Summit Therapeutics PLC (ADR) (NASDAQ: SMMT) shares fell 16.4 percent to $12.75 in pre-market trading. Summit Therapeutics priced public offering of 1.459 million ADS's at $12.00 per ADS.
  • Array Biopharma Inc (NASDAQ: ARRY) shares fell 8.8 percent to $9.61 in pre-market trading. Array Biopharma reported a $175 million offering of common stock.
  • Hertz Global Holdings, Inc (NYSE: HTZ) fell 5.8 percent to $22.55 in pre-market trading. Morgan Stanley downgraded Hertz Global from Equal-Weight to Underweight.
  • Century Aluminum Co (NASDAQ: CENX) shares fell 5.2 percent to $18.80 in pre-market trading after slipping 0.20 percent on Wednesday.
  • Editas Medicine Inc (NASDAQ: EDIT) shares fell 5.1 percent to $20.00 in pre-market trading after surging 5.77 percent on Wednesday.
  • Qiwi PLC (NASDAQ: QIWI) fell 5.1 percent to $17.10 after rising 0.11 percent on Wednesday.
  • Opiant Pharmaceuticals Inc (NASDAQ: OPNT) fell 5 percent to $35.15 in pre-market trading after gaining 2.72 percent on Wednesday.
  • Insmed Incorporated (NASDAQ: INSM) fell 4.7 percent to $26.30 in pre-market trading after dropping 7.82 percent on Wednesday.
  • Epizyme Inc (NASDAQ: EPZM) fell 3.8 percent to $15.35 in pre-market trading. Epizyme priced 9.18 million share offering at $15.25 per share.
  • Opko Health Inc. (NASDAQ: OPK) fell 3.1 percent to $6.27 in pre-market trading. JP Morgan downgraded OPKO Health from Overweight to Neutral and lowered the price target from $12.00 to $7.00.
 

Related Articles (ARRY + ALV)

View Comments and Join the Discussion!

Posted-In: #PreMarket Gainers LosersNews Movers & Shakers Pre-Market Outlook Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com